1. Potential biomarkers of immune protection in human leishmaniasis

   • Mahmoud Nateghi Rostami
   • Ali Khamesipour

   Review 02 May 2021 Pages: 81 - 100

2. An update: the emerging evidence of complement involvement in COVID-19

   • Qin Li
   • Zi Chen

   Review Open access 03 April 2021 Pages: 101 - 109

   

3. Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae

   • Naoko Fuji
   • Michael E. Pichichero
   • Ravinder Kaur

   Original Investigation 22 March 2021 Pages: 111 - 120

   

4. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis

   • Jing Yang
   • Lin Wu
   • Liying Fang

   Original Investigation 22 April 2021 Pages: 121 - 132

   

5. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis

   • Rafaella R. Costa
   • João A. Oliveira-da-Silva
   • Eduardo A. F. Coelho

   Original Investigation 18 April 2021 Pages: 133 - 147

   

6. The role of HIF-1α in BCG-stimulated macrophages polarization and their tumoricidal effects in vitro

   • Pei Zhu
   • Yuyang Hou
   • Zehua Dong

   Original Investigation 11 May 2021 Pages: 149 - 156

   

7. What we actually know about the pathogenicity of Bacteroides pyogenes

   • Anna Majewska
   • Marta Kierzkowska
   • Dariusz Kawecki

   Original Investigation Open access 02 May 2021 Pages: 157 - 163

8. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission

   • Friederike Häuser
   • Martin F. Sprinzl
   • Niels A. Lemmermann

   Rapid Communication Open access 15 April 2021 Pages: 165 - 171